My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1110

    1.

    Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.

    Nakamura A, Shikata K, Hiramatsu M, Nakatou T, Kitamura T, Wada J, Itoshima T, Makino H.

    Diabetes Care. 2005 Dec;28(12):2890-5.PMID: 16306550 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Relationships of plasma interleukin-18 concentrations to hyperhomocysteinemia and carotid intimal-media wall thickness in patients with type 2 diabetes.

    Aso Y, Okumura K, Takebayashi K, Wakabayashi S, Inukai T.

    Diabetes Care. 2003 Sep;26(9):2622-7.PMID: 12941729 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study.

    Araki S, Haneda M, Koya D, Sugimoto T, Isshiki K, Chin-Kanasaki M, Uzu T, Kashiwagi A.

    Diabetologia. 2007 Apr;50(4):867-73. Epub 2007 Jan 16.PMID: 17225121 [PubMed - indexed for MEDLINE]Related articles

    4.

    Ultrasonographically assessed carotid atherosclerosis in Japanese type 2 diabetic patients: Role of nonesterified fatty acids.

    Taniguchi A, Nakai Y, Fukushima M, Teramura S, Hayashi R, Hama K, Marumoto K, Watanabe T, Yoshioka I, Sakaguchi K, Kishimoto H, Matsushita K, Okumura T, Tokuyama K, Nagasaka S, Sakai M.

    Metabolism. 2002 May;51(5):539-43.PMID: 11979382 [PubMed - indexed for MEDLINE]Related articles

    5.

    Interleukin-6 and C-reactive protein in pathogenesis of diabetic nephropathy: new evidence linking inflammation, glycemic control, and microalbuminuria.

    Choudhary N, Ahlawat RS.

    Iran J Kidney Dis. 2008 Apr;2(2):72-9.PMID: 19377212 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Association of C-reactive protein with early-stage carotid atherosclerosis in Japanese patients with early-state type 2 diabetes mellitus.

    Mita T, Watada H, Uchino H, Shimizu T, Hirose T, Tanaka Y, Kawamori R.

    Endocr J. 2006 Oct;53(5):693-8. Epub 2006 Aug 23.PMID: 16926521 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.

    Navarro JF, Mora C, Gómez M, Muros M, López-Aguilar C, García J.

    Nephrol Dial Transplant. 2008 Mar;23(3):919-26. Epub 2007 Oct 2.PMID: 17911088 [PubMed - indexed for MEDLINE]Related articles

    8.

    Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus.

    Fukui M, Tanaka M, Shiraishi E, Harusato I, Hosoda H, Asano M, Kadono M, Hasegawa G, Yoshikawa T, Nakamura N.

    Metabolism. 2008 May;57(5):625-9.PMID: 18442624 [PubMed - indexed for MEDLINE]Related articles

    9.

    Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes.

    Jaffa AA, Durazo-Arvizu R, Zheng D, Lackland DT, Srikanth S, Garvey WT, Schmaier AH; DCCT/EDIC Study Group.

    Diabetes. 2003 May;52(5):1215-21.PMID: 12716755 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy.

    Fujita H, Morii T, Koshimura J, Ishikawa M, Kato M, Miura T, Sasaki H, Narita T, Ito S, Kakei M.

    Endocr J. 2006 Dec;53(6):745-52. Epub 2006 Sep 12.PMID: 16966829 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Serum high sensitivity C-reactive protein is associated with carotid intima-media thickness in type 2 diabetes.

    Kang ES, Kim HJ, Kim YM, Lee S, Cha BS, Lim SK, Kim HJ, Lee HC.

    Diabetes Res Clin Pract. 2004 Dec;66 Suppl 1:S115-20.PMID: 15563960 [PubMed - indexed for MEDLINE]Related articles

    12.

    Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients.

    Navarro JF, Mora C, Muros M, García J.

    Nephrol Dial Transplant. 2006 Dec;21(12):3428-34. Epub 2006 Aug 25.PMID: 16935891 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus.

    Kado S, Nagase T, Nagata N.

    Acta Diabetol. 1999 Jun;36(1-2):67-72.PMID: 10436255 [PubMed - indexed for MEDLINE]Related articles

    14.

    Serum levels of interleukin-6 (Il-6), interleukin-18 (Il-18) and C-reactive protein (CRP) in patients with type-2 diabetes and acute coronary syndrome without ST-segment elevation.

    Souza JR, Oliveira RT, Blotta MH, Coelho OR.

    Arq Bras Cardiol. 2008 Feb;90(2):86-90. English, Portuguese. PMID: 18392379 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus.

    Navarro JF, Mora C, Maca M, Garca J.

    Am J Kidney Dis. 2003 Jul;42(1):53-61.PMID: 12830456 [PubMed - indexed for MEDLINE]Related articles

    16.

    Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes.

    Pu LJ, Lu L, Xu XW, Zhang RY, Zhang Q, Zhang JS, Hu J, Yang ZK, Ding FH, Chen QJ, Lou S, Shen J, Fang DH, Shen WF.

    Cardiovasc Diabetol. 2006 Dec 20;5:27.PMID: 17178005 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.

    Takebayashi K, Matsumoto S, Aso Y, Inukai T.

    J Diabetes Complications. 2006 Mar-Apr;20(2):98-104.PMID: 16504838 [PubMed - indexed for MEDLINE]Related articles

    18.

    Serum adiponectin is increased in type 1 diabetic patients with nephropathy.

    Saraheimo M, Forsblom C, Fagerudd J, Teppo AM, Pettersson-Fernholm K, Frystyk J, Flyvbjerg A, Groop PH; FinnDiane study group.

    Diabetes Care. 2005 Jun;28(6):1410-4.PMID: 15920060 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.

    Peng Y, Liu H, Liu F, Ouyang L, Cheng M, Gao L, Pan F, Liu Y, Chen X, Li J.

    Nephrology (Carlton). 2008 Oct;13(7):579-86.PMID: 19161364 [PubMed - indexed for MEDLINE]Related articles

    20.

    Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy.

    Moriwaki Y, Yamamoto T, Shibutani Y, Aoki E, Tsutsumi Z, Takahashi S, Okamura H, Koga M, Fukuchi M, Hada T.

    Metabolism. 2003 May;52(5):605-8.PMID: 12759891 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity